Medtronic plc has decided to pull its HeartWare ventricular assist device (HVAD) after a couple of recent recalls and slew of deaths associated with the product. The company is working with rival Abbott to get patients an alternative device.
The US Food and Drug Administration had already notified the public of two class I recalls for the HeartWare intrapericardial centrifugal left-ventricular assist device (LVAD) for advanced heart-failure patients after...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?